SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-13-012797
Filing Date
2013-10-04
Accepted
2013-10-04 13:56:45
Documents
5
Period of Report
2013-10-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K kva20131003_8k.htm 8-K 40446
2 EXHIBIT 10.1 ex10-1.htm EX-10 15951
3 EXHIBIT 10.2 ex10-2.htm EX-10 57235
4 EXHIBIT 10.3 ex10-3.htm EX-10 31235
5 EXHIBIT 99.1 ex99-1.htm EX-99 6611
  Complete submission text file 0001437749-13-012797.txt   152883
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005 3146456600
K-V Pharmaceutical Co (Filer) CIK: 0000057055 (see all company filings)

IRS No.: 430618919 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-09601 | Film No.: 131136232
SIC: 2834 Pharmaceutical Preparations